NCT04960215View on ClinicalTrials.gov

Coenzyme Q10 as Treatment for Long Term COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
Covid19Long Term Covid19
Interventions
DRUG

Coenzyme Q10

Coenzyme Q10 (myoquinon) capsule 100mg, 5 capsules a day.

DRUG

Placebo

A soft gelatin capsule containing soy oil, 5 capsules a day.

Trial Locations (1)

8200

Department of Infectious Diseases, Aarhus

Sponsors

Collaborators (1)

Pharma Nord
All Listed Sponsors
collaborator

University of Aarhus

OTHER

collaborator

Pharma Nord

INDUSTRY

lead

Aarhus University Hospital

OTHER

NCT04960215 - Coenzyme Q10 as Treatment for Long Term COVID-19 | Biotech Hunter | Biotech Hunter